Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

Astrazeneca Plc (AZNl)

BATS Europe
Currency in GBP
10,663.0
+81.0(+0.77%)
Closed

AstraZeneca (AZNl) Income Statement & Profits

Advanced Income Statement
Period Ending:
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa24,38426,61737,41744,35145,811
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+10.38%+9.16%+40.58%+18.53%+3.29%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa4,8485,24612,0058,6198,040
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa19,53621,37125,41235,73237,771
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+11.09%+9.39%+18.91%+40.61%+5.71%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa80.12%80.29%67.92%80.57%82.45%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa16,46817,00122,51526,72027,337
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+3.87%+3.24%+32.43%+18.68%+2.31%
aa.aaaa.aaaa.aaaa.aaaa.aa5,3495,9018,0499,52910,299
aa.aaaa.aaaa.aaaa.aaaa.aa11,43811,58614,67317,42218,025
aa.aaaa.aaaa.aaaa.aaaa.aa-319-486-207-231-987
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa3,0684,3702,8979,01210,434
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+77.24%+42.44%-33.71%+211.08%+15.78%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa12.58%16.42%7.74%20.32%22.78%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-635-661-733-836-918
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-3.76%-4.09%-10.89%-14.05%-9.81%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-780-738-776-917-1,219
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa145774381301
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-688-548-562-391-338
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa1,7453,1611,6027,7859,178
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa1,2221,055509216292
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-1,072-49-1,869-1,212-1,967
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa1,5483,916-2652,5016,899
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-22.33%+152.97%-106.77%+1,043.77%+175.85%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa6.35%14.71%-0.71%5.64%15.06%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa321772-380-792938
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa1,2273,1441153,2935,961
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa10852-3-5-6
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa1,3353,1961123,2885,955
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-38.05%+139.4%-96.5%+2,835.71%+81.11%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa5.47%12.01%0.3%7.41%13%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa1,3353,1961123,2885,955
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa1.032.440.082.123.84
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-39.67%+137.39%-96.76%+2,589.19%+81%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa1.032.440.082.113.81
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-39.64%+137.39%-96.76%+2,571.43%+80.57%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa1,3011,3121,4181,5481,549
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa1,3011,3131,4271,5601,562
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa2.82.82.872.92.9
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa0%0%+2.5%+1.05%0%
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa5,5756,9906,70113,94415,010